SEC Form 4 · accession 0001213900-17-003334
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas P Baker
Officer — CHIEF FINANCIAL OFFICER
Period of report
Mar 31, 2017
Accepted (ET)
Apr 4, 2017 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001448431
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $0.82 | Mar 31, 2017 | A | 200,000 | A | Jan 1, 2018 | Mar 31, 2022 | Common Stock | 200,000 | 400,000 | D |
| Stock OptionF2 | $0.82 | Mar 31, 2017 | A | 100,000 | A | Sep 30, 2017 | Mar 31, 2022 | Common Stock | 100,000 | 500,000 | D |
Explanation of responses
- F1The Stock Options were issued based on performance criteria and only vest upon target revenue achieved in 2017.
- F2The Stock Options will vest as to 50% of the shares on September 30, 2017 and 50% of the shares on March 31, 2018.